Skip to main content
Figure 3 | Breast Cancer Research

Figure 3

From: Silencing of HSulf-2 expression in MCF10DCIS.com cells attenuate ductal carcinoma in situ progression to invasive ductal carcinoma in vivo

Figure 3

HSulf-2 is expressed in ductal lesions formed in vivo in NTC derived xenografts. (A) Immunohistochemistry analysis revealed expression of HSulf-2 in central areas as well as areas surrounding basement membrane. Limited staining of HSulf-2 was observed in stromal fraction. (Magnification 20×). (B) Immunohistochemistry analysis of HSulf-2 expression in NTC at Weeks 3, 5 and 7 (Magnification 10×).

Back to article page